Keimed

Hyderabad, India Founded: 2000 • Age: 26 yrs Minicorn
Temperature-sensitive medicines are distributed via cold chain logistics by Keimed.

About Keimed

Keimed is a Healthcare company based in Hyderabad (India) founded in 2000. Temperature-sensitive medicines are distributed via cold chain logistics by Keimed. Keimed has raised $16.62 million across 2 funding rounds from investors including Mitsui & Co and Apollo Hospitals. The company has 588 employees. Keimed was last valued at $122.86 million in August 2015. Its chief executive, as recorded, is Gaurav Chaturvedi. Its Indian entity Keimed Private Limited reported revenue of ₹1,265 Cr. Keimed offers products and services including Medicine Distribution Service and Cold Chain Logistics. Its focus areas include Pharmaceutical Distributors and Diversified. Its competitors include Entero Healthcare, Sandor Medicaids and Mahaveer Medi Sales; 2 of its 3 listed competitors have raised funding.

Company details

Founded in 2000 in Hyderabad, India, Keimed operates in the pharmaceutical distribution sector. Temperature-sensitive medicines are sourced directly from manufacturers and stored in specialized facilities to preserve quality and effectiveness. A rapid logistics system is employed for timely deliveries, supported by advanced cold chain infrastructure and technology. Operations focus on efficiency across the supply chain in the Indian market.

  • Headquarters Hyderabad, India
  • Employees 588
  • Stage Minicorn
  • Sectors
    Healthcare
  • Website keimed.com
  • Social LinkedIn
  • Legal Name Keimed Private Limited
  • Date of Incorporation 10 Mar, 2000
  • Jurisdiction Chennai, Tamil Nadu, India
Key Metrics
  • Annual Revenue
    ₹1,265 Cr

    FY 2026 · +13% YoY

  • Net Profit
    ₹241 Cr

    FY 2026 · 2% margin

  • EBITDA
    ₹459 Cr

    FY 2026 · 3% margin

  • Total Equity Funding
    $16.62M (USD)

    in 2 rounds

  • Latest Funding Round
    $11.7M (USD), Series B

    Mar 2025

  • Investors
  • Employee Count
    588

Products & Services of Keimed

Keimed offers a comprehensive portfolio of products and services, including Medicine Distribution Service and Cold Chain Logistics.

Medicine Distribution Service
Pharmaceutical Services

Provides nationwide delivery of genuine, temperature-controlled medicines.

Cold Chain Logistics
Supply Chain Services

Ensures integrity of temperature-sensitive healthcare products during transport.

Funding Insights of Keimed

Keimed has successfully raised a total of $16.62M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $11.7 million completed in March 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $16.62M
  • Total Rounds 2
  • Last Round Series B — $11.7M
  • First Round $4.92M

    (Aug 2015)

  • Investors Count 2

All 2 funding rounds of Keimed with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2025$11.7MSeries B–Apollo Hospitals
–
Aug 2015$4.92MSeries A$122.86MMitsui
–
Valuation history
DateValuationStage
Aug 2015$122.86M••••••••

Last known valuation $122.86M (Aug 2015). 2 investors in total: 2 institutional.

Investors in Keimed

Keimed has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Mitsui & Co and Apollo Hospitals.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Traditional conglomerate services are provided across multiple sectors by Mitsui.
1947mitsui.comChiyoda City, Japan
Chain of multispecialty hospitals
1983apollohospitals.comChennai, India
Premium access

Investor details for Keimed

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Keimed Private Limited (Keimed)

Keimed Private Limited is the primary company behind Keimed. The boards of the 2 registered companies of Keimed currently have 8 directors; the longest-serving is Arvind Kumar Venkat, appointed in 2015. 15 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Arvind Kumar Venkat
DIN 02304618
Managing Director31 Jan 201511 yrs 9 moKeimed Private Limited
Anil Kamineni
DIN 01562283
Designated Partner07 Nov 20224 yrsKamineni Enterprises International Llp
Raj Shankar
DIN 00238790
Director19 Apr 20233 yrs 7 moKeimed Private Limited
Pankaj Patwari
DIN 08206620
Director03 Oct 20242 yrs 1 moKeimed Private Limited
Shobana Kamineni
DIN 00003836
Partner30 Dec 20241 yr 10 moKamineni Enterprises International Llp, Keimed Private Limited
Anuspala Kamineni
DIN 07486388
Partner30 Dec 20241 yr 10 moKamineni Enterprises International Llp
Upasana Konidela
DIN 02781278
Designated Partner30 Dec 20241 yr 10 moKamineni Enterprises International Llp
Puansh Kamineni
DIN 08117626
Partner30 Dec 20241 yr 10 moKamineni Enterprises International Llp, Keimed Private Limited

People of Keimed

8 people are tracked at Keimed (6 in leadership, 2 in team); the tracked headcount is 588.

NameRoleGroup
Gaurav Chaturvedi
CEOLeadership
Managing DirectorLeadership
Alok Polawar
Head - CommercialLeadership
Susmit Panja
Chief Technology OfficerLeadership
Rajeev Bahuguna
Head - SalesLeadership
Narasaiah Arigela
Chief Financial OfficerLeadership
Jagadeesh Vaddi
Gm, OperationsTeam
Swati Shradha
Senior Executive Human Resources ( Apollo Group)Team
Premium access

Complete people profiles for Keimed

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Keimed

Figures of Keimed Private Limited, the primary company behind Keimed, for FY 2026. Revenue was ₹1,265 Cr (+13% year on year). Net profit was ₹241 Cr (2% margin). EBITDA was ₹459 Cr (3% margin). Revenue has grown at a compounded annual rate of +16% over three years and +20% over five years.

  • ₹1,265 CrRevenue · FY 2026 · +13% YoY
  • ₹241 CrNet profit · 2% margin
  • ₹459 CrEBITDA · 3% margin
  • ₹6.87 CrPaid-up capital
  • 420Employees (provident fund records)
  • +16%Revenue CAGR, 3 years
  • +20%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Keimed Private Limited are on its company page.

Premium access

Detailed financial statements for Keimed

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Keimed

4 dated milestones of Keimed across 25 years, from founding to its latest funding, stage changes and deals.

  1. Founded Keimed is founded.
  2. Funding First funding round of $4.9M.
  3. Milestone Reaches Minicorn status.
  4. Funding Latest funding round, Series B, of $11.7M.

Competitors of Keimed

Keimed has 3 listed competitors in our database, 2 of them funded. They include Entero Healthcare, Sandor Medicaids and Mahaveer Medi Sales.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
enterohealthcare.com2018Mumbai, India$59.67M817
India's leading healthcare products distribution platform
sandor.co.in1995Hyderabad, India$8.98M161
Provider of medical equipment, devices, and drugs distribution services
mahaveermedi.com2016Bengaluru, India588
Serves as a distributor of a wide range of pharmaceutical drugs.
Premium access

Detailed competitors of Keimed

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Keimed

Premium access

Complete news archive for Keimed

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Keimed

Keimed was founded in 2000 and raised its 1st funding round 15 years after it was founded.

Keimed is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

Gaurav Chaturvedi is the CEO of Keimed, as recorded in our data.

Keimed is a funded company, having raised a total of $16.62M across 2 funding rounds to date. The company's 1st funding round was a Series A of $4.92M, raised on Aug 2015.

Keimed has 588 employees.

The primary company behind Keimed, Keimed Private Limited, reported revenue of ₹1,265 Cr for FY 2026, up 13% year on year.

Founded in 2000 in Hyderabad, India, Keimed operates in the pharmaceutical distribution sector. Temperature-sensitive medicines are sourced directly from manufacturers and stored in specialized facilities to preserve quality and effectiveness. A rapid logistics system is employed for timely deliveries, supported by advanced cold chain infrastructure and technology. Operations focus on efficiency across the supply chain in the Indian market.

Keimed's top competitors include Entero Healthcare, Sandor Medicaids and Mahaveer Medi Sales.

Keimed offers Medicine Distribution Service and Cold Chain Logistics.

Keimed has 2 investors. Key investors include Mitsui & Co, and Apollo Hospitals.

The valuation of Keimed is $122.86M as of Aug 2015.

Keimed is associated with 2 legal entities: Keimed Private Limited, Kamineni Enterprises International Llp.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available